Showing results (111-120 of 137) with videos related to
Sort By:
Pageof 14
Clinical Nephrology|March 1, 1984
Surgical treatment of hydrothorax complicating continuous ambulatory peritoneal dialysisC W Pattison, R S Rodger, D Adu, et al.Journal of Clinical Pathology|August 1, 1997
Expression of E-cadherin in oesophageal carcinomas from the UK and China: disparities in prognostic significanceW G Jian, S J Darnton, K Jenner, et al.Journal of Clinical Pathology|March 1, 1996
Lymphocyte infiltration in oesophageal carcinoma: lack of correlation with MHC antigens, ICAM-1, and tumour stage and gradeJ C Rockett, S J Darnton, J Crocker, et al.Journal of Clinical Pathology|November 1, 1995
Lack of correlation of P-glycoprotein expression with response to MIC chemotherapy in oesophageal cancerS J Darnton, K Jenner, R S Steyn, et al.The Journal of General Physiology|February 2, 1999
Light-dependent changes in outer segment free-Ca2+ concentration in salamander cone photoreceptorsA P Sampath, H R Matthews, M C Cornwall, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1995
Weight gain as an indicator of response to chemotherapy for oesophageal carcinomaR S Steyn, I Grenier, S J Darnton, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|August 15, 1998
A phase II trial of cisplatin and 5-fluorouracil in adenocarcinoma of the oesophagusR S Steyn, R Vijeyasingam, S J Darnton, et al.Journal of Clinical Pathology|June 1, 1995
Expression of HLA-ABC, HLA-DR and intercellular adhesion molecule-1 in oesophageal carcinomaJ C Rockett, S J Darnton, J Crocker, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|November 1, 1991
A phase II study of 5-fluorouracil, adriamycin and mitomycin-C in adenocarcinoma of the oesophagusS J Walker, S M Allen, A Steel, et al.British Journal of Cancer|January 1, 1997
Five newly established oesophageal carcinoma cell lines: phenotypic and immunological characterizationJ C Rockett, K Larkin, S J Darnton, et al.Pageof 14